News
Addressing forced resilience: Indigenous experiences with genomic medicine in British Columbia
A new study published in Genetics in Medicine examines how systemic barriers in health care shape Indigenous families’ views about genomic medicine in British Columbia. The research finds that physical and relational barriers to access, experiences of racism and persistent demands for self-advocacy impose resilience as a condition of care for Indigenous families.
New research identifies a promising target in multiple fusion-driven cancers
A new multinational study led by Dr. Poul Sorensen, distinguished scientist at BC Cancer Research Institute, professor in the UBC Faculty of Medicine and holder of the Johal Chair in Childhood Cancer Research, has been published in Cancer Discovery, a leading journal of the American Association for Cancer Research.
Dr. Samuel Aparicio, co-senior author on Nature Aging paper linking breast tissue aging to cancer risk
Dr. Samuel Aparicio, distinguished scientist at the BC Cancer Research Institute and professor at the University of British Columbia, is co-senior author on a recent paper providing the most detailed map to date of how breast tissue changes over a woman’s lifetime, revealing the role of menopause in cancer susceptibility. The study was co-led with scientists at the University of Cambridge.
Improving health outcomes in breast radiotherapy: A universal solution for every body
For patients undergoing breast radiotherapy to treat their cancer, receiving a high-quality standard of care is important – particularly given they receive treatment over several sessions.
However, this consistency can be challenging to maintain as each patient’s body is different. Positioning the breast accurately is key to ensuring the radiation targets the right area, yet variations in body shape and size can make this difficult.
Dr. David Huntsman receives 2025 Rosalind Franklin Prize for Excellence in Ovarian Cancer Research
Dr. David Huntsman has been awarded the 2025 Rosalind Franklin Prize for Excellence in Ovarian Cancer Research by the Ovarian Cancer Research Alliance (OCRA), recognizing his findings that have profoundly impacted the treatment of certain ovarian cancer subtypes.
BC Cancer Foundation is the fundraising partner of BC Cancer, which includes BC Cancer Research. Together with our donors, we are changing cancer outcomes for British Columbians by funding innovative research and personalized treatment and care.